slides · global inventory
47 Quick Win Big Bet
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 9,718
Current window 6,091-6,120
Pages 324
Rows per page 30
Loop
6,091-6,120 of 9,718
19
The chart is a mirrored bar chart (diverging bar chart) showing AE frequency by grade.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
20
The slide uses a 2D grid to map dose combinations against regulatory requirements (Project Optimus).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
26
This is a closing slide for an investor presentation.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
17
Includes a visual comparison between a 'cold' antibody and the 'hot' FPI-1434 conjugate.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
Includes medical imaging (SPECT/CT) comparing baseline vs. cold antibody intervention.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
Includes before/after PET-CT scan imagery.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
HBT Financial | Results Presentation Deck | 36 slidesHBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
21
The chart shows a significant spike in 2012 for the company, with an adjusted line to account for non-recurring items.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Before After1 hit
22
The slide uses two bar charts to illustrate financial performance metrics over two distinct time periods (2007-2010 and 2017-2023).HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Before After1 hit
23
The slide uses a bar chart for historical cost of deposits and a line chart for deposit beta trends relative to the Fed Funds Rate.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
24
The slide uses a two-column layout to contrast deposit stability with growth potential.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
25
The timeline uses a horizontal line with vertical markers for each acquisition event.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
26
Includes mention of the 'three lines of defense' model.HBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
09
Heartland Financial USA | Results Presentation Deck | 35 slidesHeartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
10
The slide uses a three-column layout with a summary footer for each column.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
11
The slide uses a four-column layout to categorize strategic initiatives into 'Enhance' and 'Invest' buckets.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
12
The slide includes a footnote regarding non-GAAP reconciliation and a visual indicator of earnings impact progression from 2024 to 2026.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
30
The slide uses a standard pharmaceutical pipeline table format to communicate clinical progress and regulatory milestones.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
31
Includes a comparative table of clinical outcomes (ORR/CR/sCR) for NXC-201 vs. competitors.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
32
The slide uses a wave-like visual to represent market segments and their associated dollar values.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & ProofLoop · Quick Win Big Bet1 hit
20
The slide uses a 2x2 grid layout to categorize strategic initiatives.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
21
Independent Bank Corp | Results Presentation Deck | 30 slidesIndependent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
13
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
14
The slide serves as a section divider or speaker introduction.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
15
Focuses on clinical trial strategy and regulatory milestones.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
16
The slide outlines the randomization, treatment arms, timeline, patient population criteria, and primary/secondary endpoints.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
17
Uses a combination of an additive equation for the value prop and a chevron-based timeline for the life cycle management.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
07
The slide uses a process flow diagram to show the funnel from potential partnerships to active clinical programs.MaxCyte | Investor Presentation Deck | 21 slides · MaxCyte
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
08
The chart shows a cumulative growth trend of partner milestones over time, with logos placed in vertical columns representing years.MaxCyte | Investor Presentation Deck | 21 slides · MaxCyte
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit